NCT06979024View on ClinicalTrials.gov

A Registered Observational Cohort Study of Myotonic Dystrophy Type 1

Enrolling by invitationOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

December 31, 2038

Study Completion Date

December 31, 2038

Conditions
Myotonic Dystrophy Type 1 (DM1)
Interventions
GENETIC

Triplet-primed PCR or Long-read sequencing

This study involves long-read sequencing in patients with Myotonic Dystrophy Type 1 (DM1) to identify specific motifs, determine the range of repeat numbers, and assess the presence of interruptions in the CTG repeat sequence. The aim is to gain insights into the genetic variability and its clinical implications in DM1.

Trial Locations (1)

350005

First Affiliated Hospital of Fujian Medical University, Fuzhou

All Listed Sponsors
lead

First Affiliated Hospital of Fujian Medical University

OTHER